TELESTO
Telesto · Home Health PE · Illustrative Composites

What HALO™ finds in home health.

Document
Composite findings
Audience
Sponsors · Operators
Engagement
Pre-LOI screen

Illustrative composites from pre-LOI brand diligence on home-health PE targets. Names and geographies are redacted; figures are ranges. Vignette labels below identify supporting evidence, not new pillar scores. Current HALO™ averages Heritage, Audience, Loyalty, and Outlook, then adjusts for Integration Drag where applicable.

Vignette 01 Red·Material EBITDA Exposure
Referrer brand decay at concentrated hospital systems quietly redirected admissions to a PE-backed competitor.
Outside-in case-manager interviews surfaced a multi-quarter decline in admissions from the platform’s most concentrated referrers, obscured in aggregates by simultaneous lower-margin Medicaid pickups. Competitor capture was real and accelerating.
EBITDA at risk$3-5M / yr EvidenceReferrer & Payer Brand Recall · Sentiment Velocity
Vignette 02 Amber·Roll-up Integration Drag
A multi-brand acquired portfolio was materially suppressing caregiver applicant flow at the consolidated platform.
Public employer-review platforms and direct applicant data showed the consolidated platform attracting meaningfully fewer qualified caregiver applicants per branch than the median branch under preserved legacy brands. Suppressed flow tied directly to documented census shortfalls.
EBITDA at risk$2-4M / yr EvidenceWorkforce Brand Risk · Roll-up Integration Drag · Consumer Visibility
Vignette 03 Amber·Payer Brand Recall Gap
MA payer network designers could not differentiate the target from regional competitors, jeopardizing planned MA-driven census growth.
Structured outside-in interviews with payer network designers at the platform’s primary target plans showed a clear majority unable to differentiate the target on brand attributes. The thesis growth model relied on a brand position the payers did not perceive.
EBITDA at risk$2-4M / yr EvidenceReferrer & Payer Brand Recall · Consumer Visibility
HALO™ framework for home health
01
Heritage
Established reputation and inherited clinical trust.
02
Audience
Discovery and recognition among families, referrers, and payers.
03
Loyalty
Durability of patient, referrer, and caregiver relationships.
04
Outlook
Forward demand and sentiment trajectory.
+
Integration Drag
Adjustment to the four-pillar average for roll-ups, not a fifth pillar. Vignette evidence is not a new pillar score.
For active home-health underwriting
HALO™ Brand Diligence: $45K, one week/five business days from kickoff and inputs (fixed agreed scope). 100-Day Brand Activation Plan: $90-110K, 3-4-week build + advisory checkpoints through Day 100. Broader portfolios/primary research and execution/creative/media/third parties separate. Complimentary Deal Screen: no fee, one business day for qualifying active deals after scope/confidentiality confirmation; one-page available-evidence triage, up to three issues/questions and deeper-diligence recommendation. Not investment go/no-go, scored assessment, investigation, or interviews.
1 dayBusiness day